Marshall Wace
LIAN

Marshall Wace’s LianBio American Depositary Shares LIAN Stock Holding History

Marshall Wace’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-206,497
Closed -$410K – 3575
2022
Q3 		$410K Sell
206,497
-16,894
-8% -$40.4K ﹤0.01% 2812
2022
Q2 		$483K Buy
223,391
+196,934
+744% +$669K ﹤0.01% 2804
2022
Q1 		$98K Sell
26,457
-126,491
-83% -$522K ﹤0.01% 3198
2021
Q4 		$942K Buy
+152,948
New +$1.75M ﹤0.01% 2502

Other funds holding LIAN

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Marshall Wace's LIAN Position: Q4 2022 in Review

Marshall Wace sold out of LianBio American Depositary Shares (LIAN) in Q4 2022, closing a stake of 206,497 shares — an estimated $410K sold.

Marshall Wace first reported a position in LIAN in Q4 2021 and held it in 4 quarters. The position peaked at $942K in Q4 2021. 40 funds tracked by Wall St. Rank hold LIAN as of Q4 2022.

  • Marshall Wace reported no remaining LianBio American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 206,497 LianBio American Depositary Shares shares in Q4 2022, an estimated $410K.
  • Marshall Wace first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 4 quarters.
  • Marshall Wace's LianBio American Depositary Shares position peaked at $942K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.